Supplementary Data from Selective Targeting of Myoblast Fusogenic Signaling and Differentiation-Arrest Antagonizes Rhabdomyosarcoma Cells

Authors:
  • VGValerie A. Granados
    Valerie A. Granados
  • UAUsha Avirneni-Vadlamudi
    Usha Avirneni-Vadlamudi
  • PDPooja Dalal
    Pooja Dalal
  • SSSamuel R. Scarborough
    Samuel R. Scarborough
  • KGKathleen A. Galindo
    Kathleen A. Galindo
  • PMPriya Mahajan
    Priya Mahajan
  • RGRene L. Galindo
    Rene L. Galindo
Open Access
Publisher website
Google Scholar
Abstract
Included here are Supplemental Methods, as well as four Supplemental Figures. These Figures show data supporting the notions that EGFR inhibitors antagonize RMS in vitro and in vivo, and that Akt1 intracellular activity is an RMS therapeutic target.